IRIS Accounts Production v25.3.0.601 11534901 Board of Directors 1.7.24 30.6.25 30.6.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11534901 2024-06-30 11534901 2025-06-30 11534901 2024-07-01 2025-06-30 11534901 2023-12-31 11534901 2024-01-01 2024-06-30 11534901 2024-06-30 11534901 ns15:EnglandWales 2024-07-01 2025-06-30 11534901 ns14:PoundSterling 2024-07-01 2025-06-30 11534901 ns10:Director1 2024-07-01 2025-06-30 11534901 ns10:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 11534901 ns10:SmallEntities 2024-07-01 2025-06-30 11534901 ns10:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 11534901 ns10:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 11534901 ns10:FullAccounts 2024-07-01 2025-06-30 11534901 ns10:Director3 2024-07-01 2025-06-30 11534901 ns10:Director4 2024-07-01 2025-06-30 11534901 ns10:Director5 2024-07-01 2025-06-30 11534901 ns10:RegisteredOffice 2024-07-01 2025-06-30 11534901 ns5:CurrentFinancialInstruments 2025-06-30 11534901 ns5:CurrentFinancialInstruments 2024-06-30 11534901 ns5:ShareCapital 2025-06-30 11534901 ns5:ShareCapital 2024-06-30 11534901 ns5:SharePremium 2025-06-30 11534901 ns5:SharePremium 2024-06-30 11534901 ns5:RetainedEarningsAccumulatedLosses 2025-06-30 11534901 ns5:RetainedEarningsAccumulatedLosses 2024-06-30 11534901 ns5:PlantMachinery 2024-07-01 2025-06-30 11534901 ns5:FurnitureFittings 2024-07-01 2025-06-30 11534901 ns5:ComputerEquipment 2024-07-01 2025-06-30 11534901 ns5:PlantMachinery 2024-06-30 11534901 ns5:FurnitureFittings 2024-06-30 11534901 ns5:ComputerEquipment 2024-06-30 11534901 ns5:PlantMachinery 2025-06-30 11534901 ns5:FurnitureFittings 2025-06-30 11534901 ns5:ComputerEquipment 2025-06-30 11534901 ns5:PlantMachinery 2024-06-30 11534901 ns5:FurnitureFittings 2024-06-30 11534901 ns5:ComputerEquipment 2024-06-30 11534901 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-06-30 11534901 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-06-30 11534901 ns5:WithinOneYear 2025-06-30 11534901 ns5:WithinOneYear 2024-06-30

REGISTERED NUMBER: 11534901 (England and Wales)

| UNAUDITED FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 30 JUNE 2025 |

| FOR |

| KALIUM HEALTH LIMITED |

| KALIUM HEALTH LIMITED (REGISTERED NUMBER: 11534901) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

| KALIUM HEALTH LIMITED |

COMPANY INFORMATION

FOR THE YEAR ENDED 30 JUNE 2025

| DIRECTORS: | F E Karet

| A Wooding

| Kidney Research Enterprises Limited

| Martlet Capital Directors Limited

| REGISTERED OFFICE: | Unit 1, Cambridge House

| Camboro Business Park

| Oakington Road, Girton

| CAMBRIDGE

| Cambridgeshire

| CB3 0QH

| REGISTERED NUMBER: | 11534901 (England and Wales)

| ACCOUNTANTS: | Staffords

| Chartered Accountants

| Unit 1, Cambridge House

| Camboro Business Park

| Oakington Road, Girton

| CAMBRIDGE

| Cambridgeshire

| CB3 0QH

| KALIUM HEALTH LIMITED (REGISTERED NUMBER: 11534901) |

BALANCE SHEET

30 JUNE 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | - |  | 29,636 |  |

CURRENT ASSETS

Debtors | 5 | 3,012 |  | 57,968 |  |

Cash at bank | 54,251 |  | 149,632 |  |

57,263 |  | 207,600 |  |

CREDITORS

Amounts falling due within one year | 6 | 1,764 |  | 15,608 |  |

NET CURRENT ASSETS | 55,499 |  | 191,992 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 55,499 |  | 221,628 |  |

CAPITAL AND RESERVES

Called up share capital | 8 | 3,178 |  | 3,144 |  |

Share premium | 2,186,566 |  | 2,186,566 |  |

Retained earnings | (2,134,245 | ) | (1,968,082 | ) |

SHAREHOLDERS' FUNDS | 55,499 |  | 221,628 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 November 2025 and were signed on its behalf by:

F E Karet - Director

| KALIUM HEALTH LIMITED (REGISTERED NUMBER: 11534901) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

1. | STATUTORY INFORMATION

| Kalium Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery | - | 25% on cost

| Fixtures and fittings | - | 33% on cost

| Computer equipment | - | 33% on cost

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| KALIUM HEALTH LIMITED (REGISTERED NUMBER: 11534901) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 JUNE 2025

2. | ACCOUNTING POLICIES - continued

| Going concern

| The financial statements have been prepared on the going concern basis, which assumes that the Company will continue as a going concern for the foreseeable future. The trading losses reported to date are consistent with the Company's business plan as it progresses its research and development activities.

| Given the investment received and the development progress achieved, together with the company's strategy of pursuing commercial partnerships, the directors have a reasonable expectation that the Company will be able to meet its liabilities as they fall due for the foreseeable future and therefore continue to adopt the going concern basis.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2024 - 7 ) .

4. | TANGIBLE FIXED ASSETS

| Fixtures |

| Plant and |  | and |  | Computer |

| machinery |  | fittings |  | equipment |  | Totals

£ | £ | £ | £ |

| COST

| At 1 July 2024 | 111,613 |  | 833 |  | 6,670 |  | 119,116 |  |

| Disposals | (51,313 | ) | (833 | ) | (4,239 | ) | (56,385 | ) |

| At 30 June 2025 | 60,300 |  | - |  | 2,431 |  | 62,731 |  |

| DEPRECIATION

| At 1 July 2024 | 84,589 |  | 257 |  | 4,634 |  | 89,480 |  |

| Charge for year | 8,451 |  | 156 |  | 1,639 |  | 10,246 |  |

| Eliminated on disposal | (32,740 | ) | (413 | ) | (3,842 | ) | (36,995 | ) |

| At 30 June 2025 | 60,300 |  | - |  | 2,431 |  | 62,731 |  |

| NET BOOK VALUE

| At 30 June 2025 | - |  | - |  | - |  | - |  |

| At 30 June 2024 | 27,024 |  | 576 |  | 2,036 |  | 29,636 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Other debtors | 3,012 |  | 57,968 |  |

| KALIUM HEALTH LIMITED (REGISTERED NUMBER: 11534901) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 JUNE 2025

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade creditors | 1,618 |  | 12,688 |  |

| Taxation and social security | - |  | 1,864 |  |

| Other creditors | 146 |  | 1,056 |  |

1,764 |  | 15,608 |  |

7. | LEASING AGREEMENTS

| Minimum lease payments under non-cancellable operating leases fall due as follows:

2025 | 2024 |

£ | £ |

| Within one year | - |  | 12,700 |  |

| The premises occupied were vacated as of 28/02/2025

8. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: |  | Class: |  | Nominal |  |  | 2025 |  |  | 2024 |

|  | value: |  |  | £ |  |  | £ |

| 306,288 |  | Ordinary |  | 1p |  |  | 3,063 |  |  | 3,031 |

| 4,888 |  | Growth |  | 1p |  |  | 49 |  |  | 115 |

| 6,641 |  | Deferred |  | 1p |  |  | 66 |  |  | - |

|  | 3,178 |  |  | 3,146 |

| The following shares were issued during the year for cash at par:

| 3,251 Ordinary shares of 1p.

| During the year, 6,641 of the Growth shares were redesignated to become Deferred shares, with the total number of shares in issue being unchanged after that event took place.

9. | RELATED PARTY DISCLOSURES

| There were no material related party transactions which were not concluded under normal market conditions.